Skip to main content

Day: March 8, 2024

KBC Group: Transparency notification regarding the KBC Group share buyback programme

On 10 August 2023 after trading hours, KBC Group NV announced a share buyback programme. Within the framework of this programme, KBC Group NV wishes to indicate that it now holds more than 3% of the shares of the company as a result of the cumulative purchases of own shares. More in particular, KBC has exceeded the notification threshold of 3% on 4 March 2024. As per close of business 4 March 2024, KBC Group NV holds 12 566 378 shares which represents 3,01% of the total number of currently issued shares being 417 305 876. In addition to the statutory threshold of 3%, the thresholds of 5% and any multiples thereof also apply for KBC Group NV. Consequently when surpassing any of these thresholds in the future during the progress of the share buyback programme on Euronext Brussels, KBC Group will provide a publicly available update. This...

Continue reading

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces that it will release its full year 2023 fiscal results on Thursday, 14 March 2024, at 07.00 AM CET. Following the release, the company will host a live webcast to discuss 2023 results and the outlook for 2024. Participants will have a chance to interact with Stijn Van Rompay, CEO and Jean-Luc Vandebroek, CFO in a question-and-answer session. The details of the event are below: Date: Thursday, 14 March Time: 02.00pm CET Registration: Hyloris Annual Results 2023 Webcast About Hyloris Pharmaceuticals SA Hyloris is a specialty biopharma company focused on innovating, reinventing,...

Continue reading

Scorpius Holdings, Inc. Announces Pricing of Public Offering

DURHAM, N.C., March 08, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the pricing of its underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $0.15 per share, for aggregate gross proceeds of $1,500,000, before deducting underwriting discounts, commissions and offering expenses. All of the shares of common stock were offered by the Company. The offering is expected to close on March 12, 2024, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes. ThinkEquity is acting as sole book-running manager for the offering. The...

Continue reading

RadNet Announces Pricing of Public Offering of Common Stock

LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a price to the public of $44.00 per share. The gross proceeds to RadNet from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $200 million. In addition, RadNet has granted the underwriters a 30-day option to purchase up to an additional 682,500 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about March 12, 2024, subject to satisfaction of customary closing conditions. RadNet...

Continue reading

Nayax Announces Pricing of Public Offering

HERZLIYA, Israel, March 07, 2024 (GLOBE NEWSWIRE) — Nayax Ltd. (NASDAQ: NYAX, “Nayax”), a global commerce enablement, payments and loyalty platform designed to help merchants scale their business, announced today the pricing of an underwritten public offering of 3,130,435 of its ordinary shares at a public offering price of $26.00 per share. Nayax is offering 2,130,435 ordinary shares and Yair Nechmad, Nayax’s Chief Executive Officer and Chairman of its board of directors, David Ben-Avi, Nayax’s Chief Technology Officer and a member of its board of directors, and Amir Nechmad, a member of Nayax’s board of directors, are offering a total of 1,000,000 ordinary shares as selling shareholders. In addition, Nayax has granted the underwriters a 30-day option to purchase up to 469,565 additional ordinary shares at the public offering...

Continue reading

Empire Petroleum Announces Commencement of Previously Announced Rights Offering

TULSA, Okla., March 07, 2024 (GLOBE NEWSWIRE) — Empire Petroleum Corporation (NYSE American: EP) (“Empire” or the “Company”), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced today that it has commenced its previously announced subscription rights offering (“Rights Offering”) pursuant to which it intends to raise gross proceeds of up to approximately $25.0 million. The Company is distributing at no charge to holders of its common stock, par value $0.001 per share (“Common Stock”), as of the close of business on March 7, 2024 (the record date for the Rights Offering), one subscription right for each share of Common Stock held. Each subscription right entitles the holder to purchase 0.161 shares of Common Stock at a subscription price...

Continue reading

Madison Pacific Properties Inc.’s residential development partnership, the Silverdale Hills Limited Partnership, receives final adoption from the City of Mission on the rezoning application submitted for the Loftus Village Project

VANCOUVER, British Columbia, March 07, 2024 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces that its Mission residential development partnership, the Silverdale Hills Limited Partnership (“Silverdale Hills LP”) has received final adoption from the City of Mission on the rezoning application the Silverdale Hills LP submitted for 11 properties on Gunn Avenue and Loftus Street. The Company has a 50% interest in the Silverdale Hills LP which currently owns approximately 1,400 acres of primarily residential designated development lands in Mission, British Columbia. On March 4, 2024, the Silverdale Hills LP received approval from the City of Mission to rezone 11 properties totalling approximately 139 acres within the Silverdale Central Neighborhood...

Continue reading

Superior Energy Services Announces Fourth Quarter 2023 Results and Conference Call

HOUSTON, March 07, 2024 (GLOBE NEWSWIRE) — Superior Energy Services, Inc. (the “Company”) reported its results for the fiscal quarter and full year ended December 31, 2023. In accordance with the Company’s Shareholders Agreement, it will host a conference call with shareholders on March 11, 2024. For the fourth quarter of 2023, the Company reported net income from continuing operations of $44.6 million, or $2.21 per diluted share, and revenue of $244.4 million. This compares to net income from continuing operations of $32.6 million or $1.62 per diluted share, and revenue of $210.4 million, for the third quarter of 2023. During the third and fourth quarters of 2023, we utilized an indirect foreign mechanism known as a Blue Chip Swap (“BCS”) to remit a total of $13.9 million U.S. dollars from Argentina through the purchase and sale...

Continue reading

Extendicare Announces 2023 Fourth Quarter and Year End Results

MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023. Results are presented in Canadian dollars unless otherwise noted. Fourth Quarter 2023 HighlightsAdjusted EBITDA(1) increased $19.5 million in Q4 to $28.7 million, driven by home health care volume growth and rate increases; growth in managed services, including full quarter impact of the Revera and Axium transactions; and funding increases and improved occupancy in long-term care (“LTC”). Home health care growth continued, with Q4 average daily volume (“ADV”) of 28,158, up 10.2% from Q4 2022 and 2.8% from the prior quarter. LTC occupancy returned to pre-pandemic levels, increasing 330 basis points (“bps”) to 97.8% in Q4 compared to Q4 2022. Beds...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.